JP Morgan Chase’s Tenaya Therapeutics TNYA Stock Holding History
Bought
Maintained
Sold
Other funds holding TNYA
JP Morgan Chase's TNYA Position: Q3 2026 in Review
JP Morgan Chase reduced its Tenaya Therapeutics (TNYA) stake by 12% in Q3 2026, selling an estimated $1.75K and leaving 17,633 shares worth $10.5K. The position accounts for ﹤0.01% of the portfolio, ranked #7111.
JP Morgan Chase first reported a position in TNYA in Q3 2021 and has held it in 20 quarters since. The position peaked at $7.37M in Q4 2024. 97 funds tracked by Wall St. Rank hold TNYA as of Q3 2026.
- JP Morgan Chase held 17,633 shares of Tenaya Therapeutics worth $10.5K as of Q3 2026.
- JP Morgan Chase sold 2,399 Tenaya Therapeutics shares in Q3 2026, an estimated $1.75K.
- Tenaya Therapeutics made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #7111 holding.
- JP Morgan Chase first reported a position in Tenaya Therapeutics in Q3 2021 and has held it in 20 quarters since.
- JP Morgan Chase's Tenaya Therapeutics position peaked at $7.37M in Q4 2024.
- 97 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q3 2026.
Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.